Ipsen at a glance

Innovation for

patient care

Press releases

26 January 2015

Ipsen announces topline results of two double-blind phase III studies of Dysport® in lower limb spasticity in children and in adults

07 January 2015

Ipsen announces its corporate agenda for 2015